The study participant has been diagnosed with non-rhabdomyosarcoma (NRSTS). Primary Objectives Intermediate-Risk * To estimate the 3-year event-free surviva…

Adipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma+39 more

~Estimated

~$10 – $6,250

St. Jude Children's Research HospitalNCT06239272

Observational

Biologically-Adapted, Dose-Escalated Accelerated Radiotherapy for Ewing Sarcoma (BEAR)

This clinical trial evaluates the effect of radiotherapy doses based on tumor size and tumor-specific characteristics (biologically-adapted) in treating patien…

Ewing SarcomaRound Cell Sarcoma With EWSR1-non-ETS Fusion

~Estimated

~$10 – $6,250

Mayo ClinicNCT07188532